Sarepta Q3 Revenue Falls 4.5% to $381.4 Million Year Over Year
Third-quarter 2026 revenue was $381.4 million, down from $399.4 million in the same period of 2025, primarily due to lower ELEVIDYS sales following its updated label. The company cited upcoming DM1 and FSHD datasets as opportunities for potential late-stage development.
Third-quarter 2026 revenue was $381.4M, down from $399.4M in the same 2025 period, primarily due to lower ELEVIDYS sales following its updated label. The company cited upcoming DM1 and FSHD datasets as opportunities to support potential late-stage development.Material DetailsContext by AI AnalystTh…